Delving into the Latest Updates on Nanjing Youke Biomedical Research Co., Ltd. with Synapse

Overview

主要研究目的：评价YK-2001注射液治疗成人社区获得性细菌性肺炎的有效性。次要研究目的：评价YK-2001注射液治疗成人社区获得性细菌性肺炎的安全性。通过群体PK/PD分析评价影响YK-2001注射液治疗成人社区获得性细菌性肺炎有效性和安全性的内在因素和外在因素。

[Translation]

Primary study objectives: To evaluate the effectiveness of YK-2001 injection in treating community-acquired bacterial pneumonia in adults. Secondary study objectives: To evaluate the safety of YK-2001 injection in treating community-acquired bacterial pneumonia in adults. To evaluate the intrinsic and extrinsic factors affecting the effectiveness and safety of YK-2001 injection in treating community-acquired bacterial pneumonia in adults through population PK/PD analysis.

Start Date03 Jul 2024

Sponsor / Collaborator

Nanjing YOKO Pharmaceutical Co., Ltd.

[+2]

CTR20211834

/ CompletedPhase 2

富马酸西他沙星注射液治疗急性肾盂肾炎/复杂性尿路感染的有效性与安全性随机、盲法、阳性药物平行对照、多中心Ⅱ期临床研究

[Translation] A randomized, blinded, positive drug parallel controlled, multicenter phase II clinical study on the efficacy and safety of sitafloxacin fumarate injection in the treatment of acute pyelonephritis/complicated urinary tract infection

富马酸西他沙星注射液治疗急性肾盂肾炎/复杂性尿路感染的有效性和安全性，并探索最佳有效剂量。

[Translation]

To evaluate the efficacy and safety of sitafloxacin fumarate injection in the treatment of acute pyelonephritis/complicated urinary tract infection and to explore the optimal effective dose.

Start Date10 Aug 2021

Sponsor / Collaborator

Nanjing YOKO Pharmaceutical Co., Ltd.

[+2]

CTR20192539

/ CompletedPhase 3

注射用左旋奥拉西坦改善颅脑损伤患者记忆与智能障碍的随机、双盲、阳性药/安慰剂平行对照Ⅲ期临床

[Translation] A randomized, double-blind, active drug/placebo parallel controlled phase III clinical trial of levoxiracetam for injection to improve memory and intellectual impairment in patients with craniocerebral injury

评价注射用左旋奥拉西坦改善颅脑损伤患者记忆与智能障碍的有效性和安全性。

[Translation]

To evaluate the efficacy and safety of L-oxiracetam for injection in improving memory and intellectual impairment in patients with craniocerebral injury.

Start Date27 Jul 2020

Sponsor / Collaborator

Nanjing YOKO Pharmaceutical Co., Ltd.

[+2]

100 Clinical Results associated with Nanjing Youke Biomedical Research Co., Ltd.

Login to view more data

0 Patents (Medical) associated with Nanjing Youke Biomedical Research Co., Ltd.

Login to view more data

100 Deals associated with Nanjing Youke Biomedical Research Co., Ltd.

Login to view more data

100 Translational Medicine associated with Nanjing Youke Biomedical Research Co., Ltd.

Login to view more data

Corporation Tree

Boost your research with our corporation tree data.

login

or

view full example data

Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 07 Nov 2026

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3

Other

1

Login to view more data